Total trials
59
Active
11
Phase 3
3
Total enrollment
13,718
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| tretinoin 0.025% + Z. officinale patch | — | — | — | — | — | 1 | |
| tretinoin 0.025% cream | — | — | — | — | — | 1 | |
| Investigational Drug | — | — | — | — | — | 1 |
Next readouts
- 2025-08-25
- 2025-10-20
Top conditions
- Schizophrenia Patients3
- Nutritional Intervention3
- Obesity3
- Root Canal Infection3
- Schizophrenia3
- Diabetes Mellitus (DM)2
- Functional Food2
- Stunting2
Frequently asked questions about Hasanuddin University
- How many clinical trials does Hasanuddin University have on ClinicalTrials.gov?
- Hasanuddin University is listed as the lead sponsor on 59 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hasanuddin University's trials are in Phase 3?
- 3 of Hasanuddin University's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Hasanuddin University focus on?
- Hasanuddin University's most-studied conditions on ClinicalTrials.gov are Schizophrenia Patients, Nutritional Intervention, Obesity, Root Canal Infection, Schizophrenia.
- When are Hasanuddin University's next clinical trial readouts?
- Hasanuddin University has 2 upcoming primary-completion readouts tracked here; the soonest is “Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome”, expected around 2025-08-25.